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Abstract 
Most of polypeptides containing α,β-dehydroamino acids have important biological activity, so exploration of 
synthetic method has practical significance. In this paper, dipeptides were prepared from l-threonine by protecting 
of c-terminal allyl acetate, and condensing reaction with a series of N-Boc amino acid. Then, treatment of dipeptides 
obtained with DMAP, (Boc)2O and tetramethylguanidine in the acetonitrile occured β-elimination reaction to yield 
stereoselectively dehydrodipeptides. Structures of dehydrodipeptides were confirmed by 1H NMR, 13C NMR and MS. 
Analysis of 1H NMR, 2D NMR and crystal structure showed that the dehydrodipeptides were Z-configuration.
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Background
α,β-Dehydroamino acids, as unnatural amino acids, 
are found in many natural products including the fun-
gal metabolites, β-lactam antibiotic, sulfide antibiotics, 
anticarcinoma antibiotics, phytotoxin, the antrimycins, 
tentoxin, and the phosphatase inhibitors microcystin, 
nodularin and the synthetic drugs (Gross and Meien-
hofer 1983; Valentekovich and Schreiber 1995; Botes 
et  al. 1984). In the active peptide, α,β-dehydroamino 
acids are usually used to fixed peptide main chain and 
side chain, and make its conformation keeping relatively 
stable, also can inhibit its biological degradation process. 
So α,β-dehydroamino acids play an important role in the 
design and synthesis of biological peptide and the study 
of its structure–activity relationship (Chang et  al. 1998; 
Rappoport 1994; Harburn et al. 1998; Kohno et al. 1996; 
Bierbaum 1999).
Many methods available for synthesis of α,β-
dehydroamino acids have been reported (Bonauer et  al. 
2006; Poisel and Schmidt 1976; Kolasa 1983; Maekawa 
et  al. 2004; Schmidt et  al. 1992; Trost and Dake 1997; 
Nagano and Kinoshita 2000; Chen et  al. 2005; Goodall 
and Parsons 1995; Li et  al. 1996; Somekh and Shanzer 
1983; Miller 1980; Stohimeyer et  al. 1999). However, 
these methods often are low yielding, multistep, require 
tedious purification steps to remove reagent side prod-
ucts, or incorporate unusual, difficultly obtained amino 
acid intermediates. Elimination of water from β-hydroxy-
α-amino acids is a well-established route to obtain 
β-dehydroamino acids. This method has been used for 
the preparation of dehydroalanine and dehydroaminobu-
tanoate from serine and threonine. Shioiri demonstrated 
Martin’s sulfurane is a mild, neutral and stereospecific 
dehydrative agent for the dehydrative elimination, which 
give stereospecific polypeptide with Z-configurational 
unsaturated amino acid, through removing hydroxyl 
group of β-hydroxy-α-amino acids in dipeptide or trip-
eptide (Yokokawa and Shioiri 2002). However, the dis-
advantage is that the Martin’s sulfurane is expensive. 
Ferreira reported one important and well-used approach 
involves the β-elimination reactions of serine and threo-
nine derivatives with Boc-anhydride and 4- (N,N-dimeth-
ylamino) pyridine (DMAP) (Ferreira et al. 1999; Ferreira 
et  al. 1998). Furthermore, they use the base N,N,N,N-
tetra-methylguanidine (TMG) to induce elimination of 
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the tert-butyl carbonate group from the O- (tert butyl-
oxycarbonyl)-β-hydroxyamino acid derivatives, give the 
corresponding dehydroamino acid derivative. This two-
step method can be carried out as a one-pot procedure 
and is stereoselective, giving only the Z isomer (Ferreira 
et  al. 2007). In this study, We now wish to synthesize a 
variety of dehydroamino acid derivatives by Ferreira’s 
synthetic approach and the double bond formed by dehy-
dration reaction is determined Z isomer by NOESY (Shi-




In the synthesis of dehydrodipeptides, first, we obtained 
dehydroamino acids using N-protected β-hydroxyamino 
acid esters as raw material. Then, we attempted to obtain 
dehydrodipeptides by condensation reaction of dehy-
droamino acids and amino acid. However, owing to the 
low reactivity of the α-amine group of dehydroamino 
acids and to the instability of its N-deprotected deriva-
tives, byproducts of reaction are very much, and diffi-
cult to separate by this methods. Therefore, this led us to 
investigate the applicability of Ferreira’s methodology to 
the dehydration of peptides containing β-hydroxyamino 
acids as precursors of dehydropeptides. First, dipeptides 
were prepared from two amino acid, then dehydrodi-
peptides were obtained by β elimination dehydration of 
dipeptides.
In order to prepare dipeptides containing l-threonine, 
the protection of functional groups were very important 
because of containing three activity groups in l-threo-
nine. Generally, protected groups were selected accord-
ing to the final products. In this studies, allyl group were 
used to protect carboxy terminus of amino acid. How-
ever, if l-threonine was treated with allyl bromide in 
dry DMF, besides carboxyl group, the amino group was 
reacted with allyl bromide. Thus, amino group of l-thre-
onine was protected firstly by Boc group, When N-Boc-
protected l-threonine 2 was reacted with allyl bromide 
in the presence of K2CO3 in dry DMF, it was converted 
quantitatively into 3 within 12  h. However, in the pres-
ence of NaOH, only traces of 3 were detected. This sug-
gests that the by-product may result from a base-induced 
side-reaction. Thus, the use of an alternative base could 
possibly reduce this side reaction, so K2CO3 was substi-
tuted for NaOH in the reaction of 2 with allyl bromide. 
Therefore, N-Boc-protected l-threonine 2 were treated 
with 1.2 equiv. of allyl bromide and K2CO3 in dry DMF to 
give the corresponding allyl esters of N-protected l-thre-
onine 3.
Dipeptides were readily prepared from 3 by N-depro-
tection and coupling with the N-protected amino acid 
using DIPEA/HBTU in higher yield (Scheme  1). Com-
pound 4 was treated with 1.2 molar amounts of N-pro-
tected amino acid in the presence of 1.2 molar amounts 
of HBTU and DIPEA in dichloromethane (DCM) and 
DMF at room temperature to afford the desired dipep-
tides 5a-5l in high yield (>90 %).
Ferreira’s method, one of the noteworthy stereospecific 
feature of the method was reported for the elimination 
with Boc-anhydride and 4- (N,N-dimethylamino) pyri-
dine (DMAP) and TMG by Ferreira et al. (1999). There-
fore, We treated N-Boc protected dipeptides with 3.3 
equiv. of (Boc)2O in the presence of DMAP, gave O-tert-
butyl carbonates of dipeptides, followed by direct reac-
tion with N,N,N,N-tetra-methylguanidin (TMG) without 
isolation, afforded the corresponding dehydrodipeptides 
in good yields. This two-step method can be carried 
out as a one-pot procedure. However, In order to com-
pare with Ferreira’s method, we tried to synthesize dehy-
drodipeptides by β-elimination of dipeptides containing 
β-hydroxyl group using Martin’s sulfurane. Unfortu-
nately, the treatment of dipeptides 5 with Martin’s sul-
furane did not led to the desired products. Therefore, 
Ferreira’s synthetic approach could be used efficiently 
stereoselective synthesis of dehydrodipeptides. In com-
parison with previous methods, this procedure is a one-
step process, since separation of the intermediates is 
unnecessary and theatment of intermediates with TMG 
gave the corresponding dehydrodipeptides in good yield. 
This mildness of the mothod is compatible with the pres-
ence of a variety of functional groups.
Structure characterization
To further investigate the configuration of the dehydrodi-
peptides, 6c was subjected to the 2D NMR measure-
ments. Since the NOE cross-peaks between the protons 
that are closer than 0.4 nm in space will be observed in 
NOESY spectrum and the relative intensities of these 
cross-peaks depend on the spaces between the cor-
responding protons. As can be seen from Fig.  1, the 
NOESY spectra of 6c showed clear NOE cross-peaks A 
of H1 of methyl group in double bonds and H2 of amino 
group in amide bonds, demonstrating that the substitu-
ents of methyl goup and amino group located on the 
same side of the double bond. As well as no correlation 
between H3 of double hand and H2 of amino group, 
would provide us further information about the orien-
tation of the H proton and amino group in the double 
bonds. These indicated distinctly that the double bond in 
dehydrodipeptides was Z configuration. In addition, We 
obtained single crystals suitable for X-ray crystallogra-
phy by slowly evaporating a ethyl acetate solution of 6c. 
Interestingly, X-ray crystallographic analysis of 6c reveals 
that the double bond C7–C8 in dehydrodipeptides was Z 
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configuration (Fig. 2). Therefore, the dehydro-dipeptides 
was synthesized stereoselectively by β-elimination reac-
tion using DMAP, (Boc)2O and tetramethylguanidine.
Experimental
Materials and instrumentation
All of the org. solvents used in this study were dried over 
appropriate drying agents and distilled prior to use. All 
analytical grade chemicals were purchased commer-
cially and used without further purification. Compound 
2 (Goodall and Parsons 1995) was prepared according to 
the literature procedures.
1H NMR and 13C NMR spectra were recorded on a 
Bruker AVANCE II500 instrument in CDCl3 solution, 
using tetramethylsilane as an internal reference. Elemen-
tal analyses were performed on a Perkin-Elmer 2400C 
instrument. The X-ray diffraction data were collected by 
using a Rigaku Mercury CCD AFC10 system with mono-
chromated Mo Ka radiation.
Synthesis
Boc‑L‑Thr‑OAllyl (3) 21.9  g Boc-l-threonine-OH 
(0.1 mol) was dissolved in 70 mL DMF, 16.6 g (0.12 mol) 
K2CO3 was added and cooled to 0 °C in an ice bath. 14.4 g 
(0.12  mol) Allyl bromide was added dropwise with stir-
ring by means of a separatory funnel. After the mixture 
was stirred for 1 h, the two phase solution was allowed to 
warm slowly to room temperature with vigorous stirring 
over 12 h. The solid residue was isolated by filtration. The 
solvent in the filtrate was removed in vacuo and the resi-
due was taken up in 80 mL of a saturated NaCl solution, 
and the aqueous solution was extracted with ethyl acetate 
(30  mL ×  5). The organics were combined and washed 
with 1 M KHSO4 solution, water, saturated KHCO3 and 
saturated NaCl, dried over MgSO4, the solvent removed 
under reduced pressure, evaporated in vacuo to give a 
viscous liquid, which was purified by means of silica-gel 
chromatography (Petroleum ether/Ethyl acetate = 5:1) to 
give Boc-L-Thr-OAllyl 3, the white solid with yield 91 %. 
1H NMR (500  MHz, CDCl3) 1.26 (d, 3H), 1.45 (s, 9H), 
2.89 (br, 1H), 4.26 (d, J = 8.5 Hz, 1H), 4.33 (m, 1H), 4.66 
(m, 2H), 5.29 (dd, J = 1.5 Hz, J = 10.5 Hz, 1H), 5.37 (d, 
J = 1.5 Hz, J = 16 Hz 1H), 5.49 (d, J = 9.0, 1H), 5.91 (m, 
1H). Anal. calc. for C12H21NO5 (259.14): C 55.58, H 8.16, 
N 5.40; found: C 55.63, H 8.19, N5.44.
Boc‑N‑AA‑L‑Thr‑OAllyl (5) 1.29  g (5  mmol) Boc-L-
Thr- OAllyl was taken up into a solution of trifluoro-
acetic acid (20 mL) in DCM (30 mL) and stirred for 3 h 
to remove the Boc group. After removing the solvent and 
TFA in vacuo, the crude product 4 was obtained (yield 
>  90  %), which was used to next step reaction without 
purification. The resulting compound was dissolved in 
150 mL DCM and 15 mL DMF and 6 mmol BocNH-AA-
OH and 2.25  g (6  mmol) HBTU were added, followed 
by gradual addition of 7.5  mL DIPEA, the mixture was 




















































L-Val,     5b
L-ILeu,   5c
L-Trp,    5d




L-Tyr   5i
L- -Nap  5j
D-Leu  5k
D- -Nap,   5l
(1) (2)
CH3CN
Scheme 1 The synthetic route of dehydrodipeptides
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concentrated in vacuo, then 100  mL water were added, 
and the aqueous solution was extracted with ethyl acetate 
(30  mL ×  5). The organics were combined and washed 
with water, 5  % K2CO3, 2  % HCl and water, dried over 
MgSO4, the solvent removed under reduced pressure, 
evaporated in vacuo, the crude product was purified by 
means of silica-gel chromatography (Petroleum ether/
Ethyl acetate = 5:1) to give white solids.
Boc‑L‑Leu‑L‑Thr‑OAllyl (5a) White solids, yield 95  %. 
1H NMR (500  MHz, CDCl3): δ = 0.93 (d, J =  6.5, 3H), 
0.95 (d, J =  6.0  Hz, 3H), 1.21 (d, J =  6.5  Hz, 3H), 1.43 
(s, 9H), 1.49 (m, 1H), 1.66 (m, 2H), 3.41 (br, 1H), 4.17 
(m, 1H), 4.37 (m, 2H), 4.65 (m, 2H), 5.17 (d, 1H), 5.24 (d, 
J =  10.5  Hz, 1H), 5.34 (d, J =  17.0  Hz, 1H), 5.90 (m, 1 
H), 7.05 (m, 1 H). Anal. calc. for C18H32N2O6 (372.23): 
C 58.05, H 8.66, N 7.52; found: C58.01, H 8.63, N7.54 
(see Additional file 1: Figure S1).
Boc‑L‑Val‑L‑Thr‑OAllyl (5b) White solids, yield 97  %. 
1HNMR (500 MHz, CDCl3) δ = 0.96 (d, J = 6.5, 3H), 0.98 
(d, J = 7.0 Hz, 3H), 1.21 (d, J = 6.0 Hz, 3H), 1.43 (s, 9H), 
2.07 (m, 1H), 3.46 (br, 1H), 3.95 (t, 1H), 4.38 (m, 2H), 4.64 
(d, 1H), 4.66 (m, 2H), 5.24 (d, J = 10.5 Hz, 1H), 5.34 (d, 
J = 17.0 Hz, 1H), 5.90 (m, 1 H), 6.99 (m, 1 H). Anal. calc. 
for C17H30N2O6 (358.21): C 56.97, H 8.44, N 7.82; found: 
C56.95, H 8.47, N7.88 (see Additional file 1: Figure S5).
Boc‑L‑ILeu‑L‑Thr‑OAllyl (5c) White solids, yield 93  %. 
1HNMR (500 MHz, CDCl3) δ = 0.89 (d, J = 7.0, 3H), 0.95 
Fig. 1 1H NOESY spectrum of 6c in CDCl3 at 293.2 K. Schematic representation of the polypyridyl bases and complexes 1 and 2
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(t, J = 7.0 Hz, 3H), 1.23 (d, J = 6.5 Hz, 3H), 1.23 (m, 2H), 
1.43 (s, 9H), 1.49 (m, 1H), 2.05 (m, 1H), 2.14 (br, 1H), 4.19 
(m, 1H), 4.38 (m, 2H), 4.62 (m, 1H), 4.67 (m, 1H), 4.94 (d, 
1H), 5.26 (d, J = 10.5 Hz, 1H), 5.34 (d, J = 17.0 Hz 1H), 
5.90 (m, 1 H), 6.83 (m, 1H). Anal. calc. for C18H32N2O6 
(372.23): C 58.05, H 8.66, N 7.52; found: C58.08, H 8.64, 
N7.57 (see Additional file 1: Figure S9).
Boc‑L‑Trp‑L‑Thr‑OAllyl (5d) White solids, yield 91  %. 
1HNMR (500 MHz, CDCl3) δ = 0.99 (d, J = 6.5 Hz, 3H), 
1.31 (s, 9H), 2.39 (br, 1H), 3.15 (m, 2H), 3.30 (br, 1H), 4.15 
(m, 1H), 4.45 (m, 2H), 4.47 (m, 1H), 5.12 (d, J = 10.5 Hz, 
1H), 5.19 (d, J = 17.0 Hz, 1H), 5.30 (d, J = 8.0 Hz, 1H), 
5.74 (m, 1 H), 6.88 (d, J = 9.0 Hz, 1 H). 6.99 (m, 2H), 7.07 
(m, 1H), 7.21 (d, J = 8.0 Hz, 1H), 7.52 (d, J = 8.0 Hz, 1H), 
8.47 (s, 1H); Anal. calc. for C23H31N3O6 (445.22): C 62.01, 
H 7.01, N 9.43; found: C61.98, H 7.06, N9.44 (see Addi-
tional file 1: Figure S13).
Boc‑L‑ (p‑Br)‑Phe‑L‑Thr‑OAllyl (5e) White solids, yield 
94 %. 1HNMR (500 MHz, CDCl3) δ = 1.17 (d, J = 6.0 Hz, 
3H), 1.39 (s, 9H), 2.09 (br, 1H), 2.95 (m, 1H), 3.09 (m, 1H), 
3.14 (br, 1H), 4.32 (m, 1H), 4.41 (m, 1H), 4.60 (m, 1H), 
4.65 (m, 2H), 5.23 (m, 1H), 5.26 (d, J = 10.5 Hz, 1H), 5.33 
(d, J = 17.0 Hz, 1H), 5.88 (m, 1 H), 6.97 (d, J = 9.0 Hz, 
1H), 7.09 (d, J =  8.0  Hz, 2H), 7.39 (d, J =  8.0  Hz, 2H). 
C21H29N2O6Br (484.12): C 51.97, H 6.02, N 5.77; found: 
C51.93, H 6.08, N5.81 (see Additional file 1: Figure S17).
Boc‑L‑Pro‑L‑Thr‑OAllyl (5f) White solids, yield 90  %. 
1HNMR (500 MHz, CDCl3) δ = 1.20 (d, J = 6.5 Hz, 3H), 
1.45 (s, 9H), 1.89 (m, 1H), 2.01 (m, 1H), 2.20 (m, 2H), 3.38 
(m, 1H), 3.48 (m, 2H), 4.30 (m, 1H), 4.31 (m, 1H), 4.59 
(m, 1H), 4.66 (m, 2H), 5.25 (d, J = 10.5 Hz, 1H), 5.34 (d, 
J = 17.0 Hz, 1H), 5.90 (m, 1H), 7.24 (br, 1H), Anal. calc. 
for C17H28N2O6 (356.19): C 57.29, H 7.92, N 7.86; found: 
C 57.31, H 7.91, N7.89 (see Additional file 1: Figure S21).
Boc‑L‑His‑L‑Thr‑OAllyl (5g) White solids, yield 91  %. 
1HNMR (500  MHz, CDCl3) δ  =  1.14 (d, J  =  6.0  Hz, 
3H), 1.42 (s, 9H), 1.60 (s, 9H), 2.99 (dd, J  =  6.0  Hz, 
J = 9.0 Hz, 1H), 3.06 (dd, J = 6.0 Hz, J = 9.0 Hz, 1H), 4.29 
(m, 1H), 4.53 (m, 1H), 4.56 (m, 2H), 4.62 (m, 2H), 5.23 
(d, J = 10.5 Hz, 1H), 5.31 (d, J = 17.0 Hz, 1H), 5.88 (m, 
2H), 7.19 (s, 1H), 8.03 (s, 1H), Anal. calc. for C23H36N4O8 
(496.25): C 55.63, H 7.31, N 11.28; found: C 55.60, H 7.35, 
N11.30 (see Additional file 1: Figure S25).
Boc‑L‑Phe‑L‑Thr‑OAllyl (5h) White solids, yield 96  %. 
1HNMR (500  MHz, CDCl3) δ  =  1.17 (d, J  =  6.5  Hz, 
3H), 1.40 (s, 9H), 2.51 (br, 1H), 3.06 (dd, J  =  6.0  Hz, 
J = 9.0 Hz, 1H), 3.13 (dd, J = 6.0 Hz, J = 9.0 Hz, 1H) 4.29 
(m, 1H), 4.39 (m, 1H), 4.59 (m, 1H), 4.63 (m, 1H), 4.64 
(m, 1H), 5.05 (m, 1H), 5.25 (d, J = 10.5 Hz, 1H), 5.32 (d, 
J = 17.0 Hz, 1H), 5.88 (m, 1H), 6.73 (m, 1H), 7.21–7.30 
(m, 5H). Anal. calc. for C21H30N2O6 (406.21): C 62.05, 
H 7.44, N 6.89; found: C 62.01, H 7.46, N6.93 (see Addi-
tional file 1: Figure S29).
Boc‑L‑Tyr‑L‑Thr‑OAllyl (5i) White solids, yield 93  %. 
1HNMR (500 MHz, CDCl3) δ = 1.17 (d, J = 6.0 Hz, 3H), 
1.41 (s, 9H), 2.98 (m, 2H), 4.33 (m, 2H), 4.57 (m, 1H), 
4.623 (m, 2H), 5.14 (m, 1H), 5.25 (d, J =  10.5  Hz, 1H), 
5.31 (d, J = 17.0 Hz, 1H), 5.88 (m, 1H), 6.07 (br, 1H), 6.72 
(d, J = 8.5 Hz, 2H), 7.04 (m, J = 8.5 Hz, 2H), Anal. calc. 
for C21H30N2O7 (422.21): C 59.70, H 7.16, N 6.63; found: 
C 59.72, H 7.19, N6.68 (see Additional file 1: Figure S32).
Boc‑L‑β‑Nap‑L‑Thr‑OAllyl (5j) White solids, yield 
90 %. 1HNMR (500 MHz, CDCl3) δ = 1.12 (d, J = 6.5 Hz, 
3H), 1.43 (s, 9H), 3.19 (dd, J1 = 6.0 Hz, J2 = 7.5 Hz, 1H), 
3.27 (dd, J1 = 6.0 Hz, J2 = 7.5 Hz, 1H), 4.27 (br, 1H), 4.50 
(m, 2H), 4.61 (d, J = 6.0 Hz, 2H), 4.98 (m, 3H), 5.13 (d, 
J =  8.0  Hz, 1H), 5.83 (m, 1 H), 6.85 (m, 1 H), 7.42 (m, 
1H), 7.45 (m, 2H), 7.64 (m, 1H), 7.74 (m, 3H); Anal. calc. 
for C25H32N2O6 (456.23): C65.77, H 7.07, N6.14; found: 
C65.72, H 7.04, N6.17 (see Additional file 1: Figure S36).
Boc‑D‑Leu‑L‑Thr‑OAllyl (5k) White solids, yield 92  %. 
1H NMR (500  MHz, CDCl3): δ  =  0.95 (d, J  =  6.0  Hz, 
3H), 0.96 (d, J =  4.5  Hz, 3H), 1.23 (d, J =  6.5  Hz, 3H), 
1.45 (s, 9H), 1.49 (m, 1H), 1.69 (m, 3H), 4.18 (br, 1H), 4.36 
(br, 1H), 4.59 (m, 1H), 4.66 (m, 2H), 4.90 (m, 1H), 5.25 
(d, J = 10.5 Hz, 1H), 5.34 (d, J = 17 Hz 1H), 5.90 (m, 1 
H), 6.92 (m, 1 H). Anal. calc. for C18H32N2O6 (372.23): 
C 58.05, H 8.66, N 7.52; found: C58.03, H 8.69, N7.56 
(see Additional file 1: Figure S40).
Fig. 2 The X-ray crystal structure of 6c
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Boc‑D‑β‑Nap‑L‑Thr‑OAllyl (5l) White solids, yield 
93 %. 1HNMR (500 MHz, CDCl3) δ = 1.00 (d, J = 6.0 Hz, 
3H), 1.38 (s, 9H), 3.24 (dd, J1 = 6.0 Hz, J2 = 7.0 Hz, 1H), 
3.29 (dd, J1 = 6.0 Hz, J2 = 7.0 Hz, 1H), 4.22 (br, 1H), 4.54 
(m, 2H), 4.62 (d, J = 5.5 Hz, 2H), 5.03 (m, 1H), 5.24 (d, 
J = 10.5 Hz, 1H), 5.15 (d, J = 17.0 Hz 1H), 5.87 (m, 1 H), 
6.69 (m, 1 H), 7.37 (m, 1H), 7.45 (m, 2H), 7.67 (m, 1H), 
7.79 (m, 3H); Anal. calc. for C25H32N2O6 (456.23): C65.77, 
H 7.07, N6.14; found: C65.75, H 7.09, N6.20 (see  Addi-
tional file 1: Figure S43).
Synthesis of Boc‑AA‑Z‑∆Abu‑OAllyl
Boc-N-AA-L- Thr-OAllyl 5 (2.0  mmol) was dissolved 
in 2  mL dry acetonitrile, DMAP (0.2  mmol) was added 
to above solution, followed by di-tert-butyl dicarbonate 
(3.3 equiv.) under rapid stirring at room temperature 
2  h. Then TMG (0.4  mL) was added dropwise to above 
solution, the reaction was stirred overnight. Evaporation 
at reduced pressure gave a residue that was partitioned 
between diethyl ether (100  mL) and KHSO4 (50  mL, 
1 mol dm−3). The organic phase was thoroughly washed 
with KHSO4 (1 mol dm−3), NaHCO3 (1 mol dm−3) and 
saturated brine (3×50 mL, each), and dried with MgSO4. 
Removal of the solvent afforded 8c as an oil. The crude 
product was purified by means of silica-gel chromatog-
raphy (Petroleum ether/Ethyl acetate =  8:1) to give the 
product.
Boc‑L‑Leu‑Z‑ΔAbu‑OAllyl (6a) Yellow viscous liquid, 
yield 90 %. 1H NMR (500 MHz, CDCl3): δ = 0.96 (m, 6H), 
1.45 (s, 9H), 1.54 (m, 1H), 1.76 (d, J = 7.0 Hz, 3H), 1.77 
(m, 2H), 4.27 (br, 1H), 4.65 (d, J = 4.5 Hz, 2H), 5.05 (br, 
1H), 5.24 (d, J = 5.5 Hz, 1H), 5.33 (d, J = 17.0 Hz, 1H), 
5.92 (m, 1 H), 6.83 (m, 1 H), 7.66 (br, 1H). 13C NMR 
(500 MHz, CDCl3): δ 14.20 (1C), 14.54 (1C), 22.92 (1C), 
24.73 (1C), 28.28 (3C), 40.99 (1C), 53.24 (1C), 60.42 (1C), 
65.89 (1C), 118.50 (1C), 125.97 (1C), 131.86 (1C), 134.47 
(1C), 155.82 (1C), 163.96 (1C), 171.02 (1C), 173.84 (1C); 
EI-MS m/z 377.3 (M+ + Na) (see Additional file 1: Fig-
ures S2–S4).
Boc‑L‑Val‑Z‑ΔAbu‑OAllyl (6b) White solids, m.p. 
88–89  °C, yield 92  %. 1H NMR (500  MHz, CDCl3): 
δ = 0.98 (t, J = 7.0 Hz, 3H), 1.03 (d, J = 7.0 Hz, 3H), 1.44 
(s, 9H), 1.77 (d, J =  7.0 Hz, 3H), 2.20 (br, 1H), 4.12 (br, 
1H), 4.64 (d, J = 5.5 Hz, 2H), 5.22 (d, J = 10.5 Hz, 1H), 
5.24 (br, 1H), 5.32 (d, J = 17.0 Hz, 1H), 5.91 (m, 1H), 6.837 
(m, 1H), 7.730 (br, 1H). 13C NMR (500 MHz, CDCl3): δ 
14.47 (1C), 17.84 (1C), 19.29 (1C), 28.27 (3C), 28.40 (1C), 
30.88 (1C), 59.98 (1C), 65.87 (1C), 118.51 (1C), 126.15 
(1C), 131.84 (1C), 134.67 (1C), 155.99 (1C), 163.95 (1C), 
170.45 (1C), EI-MS m/z 363.2 (M+ + Na) (see Additional 
file 1: Figures S6–S8).
Boc‑L‑ILeu‑Z‑ΔAbu‑OAllyl (6c) White solids, m.p. 
107–109  °C, yield 94  %. 1H NMR (500  MHz, CDCl3): δ 
= 0.93 (t, J = 7.0 Hz, 3H), 0.96 (d, J = 7.5 Hz, 3H), 1.26 
(m, 2H), 1.45 (s, 9H), 1.46 (m, 1H), 1.77 (d, J =  7.0 Hz, 
3H), 2.05 (br, 1H), 4.22 (br, 1H), 4.66 (d, J  =  5.5  Hz, 
2H), 5.019 (br, 1H), 5.24 (d, J  =  10.5  Hz, 1H), 5.33 (d, 
J = 17.0 Hz, 1H), 5.92 (m, 1H), 6.86 (m, 1H), 7.41 (br, 1H). 
13C NMR (500  MHz, CDCl3): δ11.71 (1C), 14.30 (1C), 
14.72 (1C), 26.37 (1C), 28.28 (3C), 28.28 (1C), 37.07 (1C), 
58.43 (1C), 65.96 (1C), 118.62 (1C), 125.82 (1C), 131.82 
(1C), 134.69 (1C), 155.92 (1C), 164.00 (1C), 170.39 (1C). 
EI-MS m/z 377.4 (M+ + Na) (see Additional file 1: Fig-
ures S10–S12).
Boc‑L‑Trp‑Z‑ΔAbu‑OAllyl (6d) White solids, m.p. 126–
127 °C, yield 88 %. 1H NMR (500 MHz, CDCl3): δ = 1.42 
(s, 9H), 1.67 (t, J =  7.0  Hz, 3H), 3.30 (m, 2H), 4.61 (m, 
3H), 5.13 (m, 1H), 5.23 (d, J  =  10.5  Hz, 1H), 5.31 (d, 
J = 17.0 Hz, 1H), 5.90 (m, 1H), 6.80 (m, 1H), 7.14 (m, 2H), 
7.21 (m, 1H), 7.36 (d, J = 8.0 Hz, 1H), 7.67 (d, J = 8.0 Hz, 
1H); 8.10 (br, 1H). 13C NMR (500 MHz, CDCl3): δ14.54 
(1C), 28.22 (3C), 29.68 (1C), 55.27 (1C), 61.61 (1C), 65.81 
(1C), 111.14 (1C), 118.41 (1C), 118.83 (1C), 119.78 (1C), 
122.27 (1C), 123.32 (1C), 125.73 (1C), 127.49 (1C), 128.5 
(1C), 131.83 (1C), 134.45 (1C), 136.17 (1C), 163.77 (1C), 
170.09 (1C), 170.09 (1C). EI-MS m/z 450.3 (M+  +  Na) 
(see Additional file 1: Figures S14–S16).
Boc‑L‑ (p‑Br) ‑Phe‑Z‑ΔAbu‑OAllyl (6e) Yellow viscous 
liquid, yield 88 %. 1H NMR (500 MHz, CDCl3): δ = 1.11 
(d, J  =  7.0  Hz, 3H), 1.59 (s, 9H), 3.27 (dd, J  =  2.5  Hz, 
J = 12.0 Hz, 1H), 3.56 (dd, J = 2.5 Hz, J = 12.0 Hz, 1H), 
4.64 (m, 2H), 4.817 (m, 1H), 5.23 (d, J =  10.5  Hz, 1H), 
5.28 (d, J = 17.0 Hz, 1H), 5.87 (m, 1H), 7.04 (d, J = 8.0 Hz, 
2H), 7.19 (m, 1H), 7.40 (d, J  =  8.0  Hz, 2H). 13C NMR 
(500 MHz, CDCl3): δ13.35 (1C), 27.85 (1C), 28.09 (3C), 
34.15 (1C), 60.45 (1C), 66.29 (1C), 118.71 (1C), 121.89 
(1C), 131.47 (1C), 131.63 (2C), 131.99 (2C), 132.49 (1C), 
144.39 (1C), 148.67 (1C), 149.82 (1C), 161.39 (1C), 168.68 
(1C). EI-MS m/z 491.2 (M+ + H + Na) (see Additional 
file 1: Figures S18–S20).
Boc‑L‑Pro‑Z‑ΔAbu‑OAllyl (6f) Yellow viscous liquid, 
yield 90 %. 1H NMR (500 MHz, CDCl3): δ = 1.48 (s, 9H), 
1.78 (d, J = 6.5 Hz 3H), 1.94 (m, 3H), 2.20 (m, 1H), 3.42 
(m, 2H), 4.38 (m, 1H), 4.65 (m, 2H), 5.24 (d, J = 10.5 Hz 
1H), 5.33 (d, J = 17.0 Hz 1H), 5.92 (m, 1H), 6.82 (m, 1H). 
13C NMR (500  MHz, CDCl3): δ 14.75 (1C), 24.61 (1C), 
28.35 (3C), 31.36 (1C), 47.16 (1C), 60.04 (1C), 61.49 (1C), 
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65.79 (1C), 118.69 (1C), 126.63 (1C), 131.97 (1C), 133.57 
(1C), 155.89 (1C), 163.94 (1C), 171.17 (1C). EI-MS m/z 
361.3 (M+ + Na) (see Additional file 1: Figures S22–S24).
Boc‑L‑His‑Z‑ΔAbu‑OAllyl (6g) Yellow viscous liq-
uid, yield 88  %. 1H NMR (500  MHz, CDCl3): δ  =  1.58 
(s, 18H), 1.73 (d, J =  7.5  Hz, 3H), 3.34 (dd, J =  6.0  Hz, 
J = 8.5 Hz, 1H), 3.56 (dd, J = 6.0 Hz, J = 8.5 Hz, 1H), 4.66 
(m, 2H), 4.75 (m, 1H), 5.23 (d, J = 10.5 Hz 1H), 5.311 (d, 
J = 17.0 Hz 1H), 5.90 (m, 1H), 7.14 (s, 1H), 7.33 (m, 1H), 
7.90 (s, 1H). 13CNMR (500  MHz, CDCl3): δ12.82 (1C), 
27.00 (3C), 26.83 (3C), 26.69 (1C), 28.67 (1C), 58.18 (1C), 
65.19 (1C), 114.39 (1C), 117.55 (1C), 121.45 (1C), 130.55 
(1C), 135.49 (1C), 136.04 (1C), 143.58 (1C), 147.46 (1C), 
149.45 (1C), 160.83 (1C), 168.29 (1C). EI-MS m/z 479.3 
(M+ + H) (see Additional file 1: Figures S26–S28).
Boc‑L‑Phe‑Z‑ΔAbu‑OAllyl (6h) White solids, m.p. 108–
109 °C, yield 91 %. 1H NMR (500 MHz, CDCl3): δ = 1.41 
(s, 9H), 1.70 (d, J  =  7.0  Hz, 3H), 3.06 (dd, J  =  6.5  Hz, 
J = 7.5 Hz, 1H), 3.09 (dd, J = 6.5 Hz, J = 7.5 Hz, 1H), 4.49 
(m, 1H), 4.64 (m, 2H), 5.00 (m, 1H), 5.246 (d, J = 11.5 Hz 
1H), 5.312 (d, J  =  17.0  Hz, 1H), 5.90 (m, 1H), 6.83 (q, 
J  =  7.0  Hz, 1H), 7.25 (m, 5H). 13C NMR (500  MHz, 
CDCl3): δ  =  14.55 (1C), 28.24 (3C), 38.63 (1C), 52.31 
(1C), 55.90 (1C), 70.26 (1C), 125.75 (1C), 126.99 (1C), 
128.69 (3C), 129.40 (3C), 134.53 (1C), 136.45 (1C), 
155.55 (1C), 164.63 (1C), 169.72 (1C). EI-MS m/z 411.3 
(M+ + Na) (see Additional file 1: Figures S30, S31)
Boc‑L‑Tyr‑Z‑ΔAbu‑OAllyl (6i) White solids, m.p. 
87–89  °C, yield 92  %. 1H NMR (500  MHz, CDCl3): 
δ  =  1.41 (s, 9H), 1.69 (d, J  =  7.0  Hz, 3H), 3.03 (dd, 
J1  =  6.0  Hz, J2  =  8.0  Hz, 1H), 3.17 (dd, J1  =  6.0  Hz, 
J2  =  8.0  Hz, 1H), 4.48 (m, 1H), 4.63 (d, J  =  6.0  Hz, 
2H), 5.07 (m, 1H), 5.23 (d, J  =  10.5  Hz, 1H), 5.32 (d, 
J  =  17.0  Hz, 1H), 5.90 (m, 1H), 6.82 (m, 1H), 7.10 (d, 
J = 8.0 Hz, 2H), 7.5 (d, J = 8.0 Hz, 2H). 7.48 (br, 1H), 13C 
NMR (500 MHz, CDCl3): δ14.59 (1C), 27.70 (3C), 28.25 
(1C), 37.14 (1C), 55.76 (1C), 65.93 (1C), 118.55 (1C), 
121.48 (2C), 125.77 (1C), 130.37 (2C), 131.85 (1C), 134.74 
(1C), 150.09 (1C), 151.84 (1C), 155.53 (1C), 163.81 (1C), 
169.60 (1C). EI-MS m/z 405.2 (M+ + 1) (see Additional 
file 1: Figures S33–S35).
Boc‑L‑β‑Nap‑Z‑Δabu–OAllyl (6j) White solids, 
m.p. 108–109  °C, yield 93  %. 1H NMR (500  MHz, 
CDCl3): δ =  0.64 (d, J =  7.0 Hz, 3H), 1.67 (s, 9H), 3.50 
(dd J  =  2.5  Hz, J  =  11.5  Hz, 1H), 3.77 (d, J  =  5.0  Hz, 
J  =  9.0  Hz, 1H), 4.63 (m, 2H), 4.91 (m, 1H), 5.22 (d, 
J  =  11.5  Hz, 1H), 5.30 (d, J  =  17.0  Hz, 1H), 5.87 (m, 
1H), 7.06 (q, J  =  7.5  Hz, 1H), 7.20 (m, 1H), 7.44 (m, 
2H), 7.70 (s, 1H), 7.74 ( (m, 3H).13C NMR (500  MHz, 
CDCl3): δ12.97 (1C), 27.73 (1C), 28.15 (3C), 34.87 (1C), 
60.92 (1C), 66.22 (1C), 118.65 (1C), 122.11 (1C), 126.11 
(1C), 126.38 (1C), 127.56 (1C), 128.55 (1C), 129.16 (1C), 
130.98 (1C), 131.50 (1C), 132.67 (1C), 133.40 (1C), 144.45 
(1C), 148.77 (1C), 149.88 (1C), 161.45 (1C), 168.99 (1C), 
171.17 (1C). EI-MS m/z 461.3 (M+ + Na) (see Additional 
file 1: Figures S37–S39).
Boc‑D‑Leu‑Z‑ΔAbu‑OAllyl (6k) Yellow viscous liq-
uid, yield 89  %. 1H NMR (500  MHz, CDCl3): δ  =  0.96 
(t, J =  6.5  Hz, 6H), 1.46 (s, 9H), 1.56 (m, 2H), 1.66 (m, 
2H), 1.75 (d, J  =  7.0  Hz, 3H), 4.22 (br, 1H), 4.65 (d, 
J = 6.0 Hz, 2H), 4.90 (br, 1H), 5.26 (d, J = 10.5 Hz, 1H), 
5.35 (d J = 17.0 Hz, 1H), 5.92 (m, 1H), 6.85 (m, 1H), 7.48 
(br, 1H). 13C NMR (500 MHz, CDCl3): δ14.21 (1C), 14.53 
(1C), 22.92 (1C), 24.73 (1C), 28.29 (3C), 41.00 (1C), 53.24 
(1C), 60.44 (1C), 65.89 (1C), 118.50 (1C), 125.97 (1C), 
131.83 (1C), 134.47 (1C), 155.84 (1C), 163.99 (1C), 171.02 
(1C), 173.88 (1C); EI-MS m/z 355.2 (M+ + H) (see Addi-
tional file 1: Figures S41, S42).
Boc‑D‑β‑Nap‑Z‑Δabu–Oallyl (6l) White solids, m.p. 
109–110  °C, yield 92  %. 1H NMR (500  MHz, CDCl3): 
δ  =  0.65 (d, J  =  7.5  Hz, 3H), 1.61 (s, 9H), 3.49 (dd, 
J = 2.5 Hz, J = 11.5 Hz, 1H), 3.770 (d, J = 5.0 Hz, J = 9.0 Hz, 
1H), 4.62 (m, 2H), 4.90 (m, 1H), 5.22 (d, J = 10.5 Hz, 1H), 
5.26 (d, J = 17.0 Hz, 1H), 5.86 (m, 1H), 7.05 (q, J = 7.5 Hz, 
1H), 7.21 (m, 1H), 7.44 (m, 2H), 7.71 (s, 1H), 7.74 (m, 3H). 
13C NMR (500  MHz, CDCl3): δ12.97 (1C), 21.07 (1H), 
28.14 (3C), 34.87 (1C), 60.92 (1C), 66.21 (1C), 118.63 (1C), 
122.10 (1C), 126.11 (1C), 126.38 (1C), 127.63 (1C), 128.54 
(1C), 129.15 (1C), 130.96 (1C), 131.50 (1C), 132.68 (1C), 
133.40 (1C), 144.43 (1C), 148.77 (1C), 149.87 (1C), 161.44 
(1C), 168.98 (1C), 171.18 (1C). EI-MS m/z 461.2 (M+ + Na) 
(see Additional file 1: Figures S44, S45).
Conclusions
α,β-Dehydroamino acids play an important role in the 
design and synthesis of biological peptide and the study 
of its structure-activity relationship, while The synthesis 
of peptides containing dehydroamino acids were a chal-
lenge. A variety of dehydroamino acid derivatives were 
synthesized. The results showed that this methods could 
be carried out as a one-pot procedure, and had high ste-
reoselectivity. 2D NMR NOESY and X-ray crystal diffrac-
tion determined Z configuration of double bond.
Supplementary information
All additional information pertaining to characterization 
of the complexes using 1H NMR, 13C NMR and EI-MS 
spectra are given in the supporting information available 
at XXX.
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